TBPH 8-K 2026-09-18

Theravance Biopharma, Inc. (TBPH) 8-K dated 2026-09-18 — accession 0001104659-26-108980. This URL is the filing, not the TBPH hub.

Theravance Biopharma, Inc. (TBPH) is a biotechnology company listed on NASDAQ.

Theravance Biopharma, Inc. filed a 8-K on 2026-09-18. Accession 0001104659-26-108980.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TBPH revenue for 2026-06-30 was $20.7M. Net income was -$5.9M. Revenue was up 17.1% from 2026-03-31 to 2026-06-30. TBPH currently screens at market cap $861.5M.

Not investment advice. The TBPH SEC hub lists recent forms. The stock page is the research view.